Recent developments of metal-based compounds against fungal pathogens
Y Lin, H Betts, S Keller, K Cariou… - Chemical Society Reviews, 2021 - pubs.rsc.org
This review provides insight into the rapidly expanding field of metal-based antifungal
agents. In recent decades, the antibacterial resistance crisis has caused reflection on many …
agents. In recent decades, the antibacterial resistance crisis has caused reflection on many …
Piano stool Ru (II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade
The popularity of RAPTA-C in in vivo studies has steered the way for complexes of the type
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …
Half-sandwich ruthenium arene complexes bearing clinically approved drugs as ligands: The importance of metal–drug synergism in metallodrug design
C Sumithaa, M Ganeshpandian - Molecular pharmaceutics, 2023 - ACS Publications
A novel strategy in metallodrug discovery today is incorporating clinically approved drugs
into metal complexes as coordinating ligands. Using this strategy, various drugs have been …
into metal complexes as coordinating ligands. Using this strategy, various drugs have been …
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis
AS Nagle, S Khare, AB Kumar, F Supek… - Chemical …, 2014 - ACS Publications
Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …
Current drug therapy and pharmaceutical challenges for Chagas disease
One of the most significant health problems in the American continent in terms of human
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …
Metal compounds against neglected tropical diseases
Many first-line treatments for neglected tropical diseases identified by the World Health
Organization (WHO) are limited by one or more of the following: the development of drug …
Organization (WHO) are limited by one or more of the following: the development of drug …
Enhancing the activity of drugs by conjugation to organometallic fragments
P Chellan, PJ Sadler - Chemistry–A European Journal, 2020 - Wiley Online Library
Resistance to chemotherapy is a current clinical problem, especially in the treatment of
microbial infections and cancer. One strategy to overcome this is to make new derivatives of …
microbial infections and cancer. One strategy to overcome this is to make new derivatives of …
Ruthenium complexes in the fight against pathogenic microorganisms. An extensive review
AC Munteanu, V Uivarosi - Pharmaceutics, 2021 - mdpi.com
The widespread use of antibiotics has resulted in the emergence of drug-resistant
populations of microorganisms. Clearly, one can see the need to develop new, more …
populations of microorganisms. Clearly, one can see the need to develop new, more …
New insights on transition metal coordination compounds with biological active azole and nitroimidazole derivatives
R Navarro-Peñaloza, B Landeros-Rivera… - Coordination Chemistry …, 2023 - Elsevier
In this review we have selected some notable examples of azoles and nitroimidazoles and
their coordination compounds with previously reported biological effectiveness. In an effort …
their coordination compounds with previously reported biological effectiveness. In an effort …
Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents
Metallodrugs have a central role in the treatment and diagnosis of diseases. To overcome
potential toxicity and equip metal-based anticancer agents with biological activity, the choice …
potential toxicity and equip metal-based anticancer agents with biological activity, the choice …